![David M. Spencer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David M. Spencer
No open positions remaining
Profile
David M.
Spencer was the founder of Bellicum Pharmaceuticals, Inc. founded in 2004, where he held the title of Chief Technology Officer from 2018 to 2019.
He also held the position of Professor and Vice Chairman-Pathology & Immunology at Baylor College of Medicine and was the Director & Chief Scientific Officer at Kiromic Biopharma, Inc. Dr. Spencer earned a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the University of California San Diego.
Former positions of David M. Spencer
| Companies | Position | End |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Founder | 01/03/2019 |
| KIROMIC BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of David M. Spencer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiromic Biopharma, Inc.
 Kiromic Biopharma, Inc. BiotechnologyHealth Technology Develops cancer engineered immunotherapies | Health Technology |
- Stock Market
- Insiders
- David M. Spencer
